Overview

Allan Huber "Bud" Selig (born July 30, 1934) is an American baseball executive best known for his long influence on Major League Baseball. He served as acting Commissioner beginning in 1992, was named the official Commissioner in 1998, and held the office until 2015. After leaving the commissioner's office he received the honorary title of Commissioner Emeritus. Over several decades Selig shaped the sport through administrative reforms, postseason restructuring and commercial initiatives, while also presiding during the era of performance-enhancing drug controversies.

Early life and the Milwaukee Brewers

Selig grew up in the Midwest and entered professional baseball as an owner and team executive. He is closely associated with the Milwaukee Brewers franchise and is credited with bringing major league baseball back to Milwaukee after the city had been without a team. For many years he served as the club's principal owner and president, a background that influenced his later priorities as baseball's chief executive.

Acting and permanent commissioner

Selig first became acting Commissioner of Baseball in the early 1990s and was confirmed as the sport's official Commissioner later in the decade. In that role he was responsible for negotiating with club owners and the players' union, overseeing competitive and commercial policy for the game, and responding to legal and congressional scrutiny of the sport. He remained a visible public figure and a central decision-maker for more than two decades.

Reforms and initiatives

During Selig's administration baseball adopted several important changes intended to modernize the game and broaden its appeal. Major initiatives included:

  • Postseason expansion: introduction and expansion of wild-card berths and additional playoff rounds to increase postseason participation.
  • Interleague play: the regular-season scheduling of games between clubs from the American and National Leagues, which altered traditional scheduling patterns.
  • Scheduling and alignment: divisional realignment and scheduling adjustments aimed at competitive balance and geographic considerations.
  • Revenue and competitive-balance measures: steps toward revenue sharing and measures intended to support smaller-market teams.
  • Technology and rules: the introduction of limited instant replay and other rule changes to improve accuracy and pace of play.

Steroid era and investigations

Selig's tenure coincided with the so-called steroid era in baseball. Under his administration Major League Baseball commissioned an independent investigation into performance-enhancing drug use and over time implemented progressively stricter testing policies and penalties. The handling of this issue drew both criticism and later praise: critics argued MLB acted too slowly in the early years, while supporters note the eventual adoption of stronger testing and discipline.

Controversies and legacy

Selig's time as commissioner included notable controversies and challenges. He was a central figure during labor disputes that affected fan trust and attendance, and his dual background as a long-time owner and commissioner drew periodic concerns about conflicts of interest. Supporters credit him with modernizing the sport, expanding its national footprint and stabilizing its finances; critics cite labor strife and the delayed response to performance-enhancing drugs as lasting blemishes.

After the commissioner's office

After stepping down from daily leadership, Selig continued to serve as Commissioner Emeritus and remained active in public discussions about the game's history and governance. His influence on Major League Baseball's structure and policies is evident in several features of the modern game, and his tenure remains a central chapter in baseball's late-20th and early-21st century evolution.